Results 41 to 50 of about 10,160 (204)
Antiviral activity of a crude extract of Thalassia testudinum Banks ex König against the human enteroviruses echovirus 9 and coxsackievirus A16 [PDF]
Context: Echovirus 9 (E9) and coxsackievirus A16 (CVA16) are etiological agents of aseptic meningitis and hand, foot, and mouth disease, respectively. Currently, there are no approved antiviral drugs against these viruses.
Liena de R. Ponce Rey +6 more
doaj +1 more source
Rigvir® is a cell-adapted, oncolytic virotherapy enterovirus, which derives from an echovirus 7 (E7) isolate. While it is claimed that Rigvir® causes cytolytic infection in several cancer cell lines, there is little molecular evidence for its oncolytic ...
Eero Hietanen +2 more
doaj +1 more source
Infectious Entry Pathway of Enterovirus B Species
Enterovirus B species (EV-B) are responsible for a vast number of mild and serious acute infections. They are also suspected of remaining in the body, where they cause persistent infections contributing to chronic diseases such as type I diabetes. Recent
Varpu Marjomäki +2 more
doaj +1 more source
Enteroviruses are common causes of infections of the central nervous system (CNS) that in temperate climates tend to peak in the summer. The aim of the study was to describe epidemiology, drivers of seasonality, and types of enteroviruses causing ...
Kacper Toczylowski +5 more
doaj +1 more source
A Three-Dimensional Cell Culture System To Model RNA Virus Infections at the Blood-Brain Barrier
The blood-brain barrier (BBB) comprises the foremost protective barrier in the brain and is composed in part of a layer of microvascular endothelial cells that line the capillaries surrounding the brain.
John C. Bramley +5 more
doaj +1 more source
Overview of systematic reviews evaluating the benefits and harms of herbal medicines for management of ARIs. ABSTRACT Hundreds of herbal medicines are currently marketed for the management of acute respiratory infections (ARIs). However, there is uncertainty about their benefits and harms, and clinical guidance remains unclear.
Fariba Aghajafari +11 more
wiley +1 more source
This study reports D34 as the first PROTAC degrader that targets the 3C protease of picornaviruses. D34 effectively degrades EV71 3C protease via the ubiquitin‐proteasome pathway. More importantly, D34 exhibits a high resistance barrier and shows broad‐spectrum antiviral activity against multiple picornaviruses, highlighting its potential as a novel ...
Weilong Deng +9 more
wiley +1 more source
Localized exanthem due to echovirus 9.
Exanthem caused by Echovirus 9.
Francesco Broccolo +20 more
core +1 more source
Countries which are experiencing recent or current epidemics of the kind reported in the Eurosurveillance Weekly report of 14 February entitled ‘Recent increases in incidence of echoviruses 13 and 30 around Europe’ (020214) are encouraged to contact Franky Lever (flever@phls.org.uk), who will be investigating enterovirus incidence in more detail as ...
openaire +1 more source
By leveraging this homodimerization mechanism, molecular glues were rationally designed to induce dysfunctional 3A dimerization, thereby restoring antiviral RNAi. The optimal molecular glue, VTP‐32, demonstrated potent and pan‐enterovirus (groups A, B, D) antiviral effects.
Yuan Fang +13 more
wiley +1 more source

